According to an assessment cited on Sunday by the NZZ am Sonntag, work breaks due to mental health issues have increased by 20% this year compared to 2021.
According to Andreas Heimer of PK Rück, a company specialising in pension fund reinsurance, this is not a catch-up effect after the Covid pandemic but a structural one. The cases that have been identified are serious: on average, an affected worker is absent for 11 months.
New kinds of mental illnesses are being reported by employees such as post-traumatic stress disorders, adjustment disorders, fatigue syndrome and post-Covid syndrome. This could have a knock-on effect on the number of people claiming disability insurance. Last year, the number of new disability insurance claimants rose by 16%, and one in two of these cases was of psychological origin.
Le Matin Dimanche, which also reports on this significant increase in sick leave for psychological reasons, states that 70% of those affected are in employment. Economic losses linked to these illnesses are estimated at more than CHF20 billion each year, according to the Organization for Economic Cooperation and Development (OECD).
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Covid: Why the post-pandemic reset is easier said than done
This content was published on
Switzerland is trying to get back to “normal” after two years of pandemic-related restrictions. There are mental health implications.
Why burnout is such a controversial issue in Switzerland
This content was published on
Burnout is still poorly understood, despite a new classification by world health authorities. How is Switzerland coming to terms with the syndrome?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.